Načítá se...

Past and current perspective on new therapeutic targets for Type-II diabetes

Loss of pancreatic β-cell function is a hallmark of Type-II diabetes mellitus (DM). It is a chronic metabolic disorder that results from defects in both insulin secretion and insulin action. Recently, United Kingdom Prospective Diabetes Study reported that Type-II DM is a progressive disorder. Altho...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Drug Des Devel Ther
Hlavní autoři: Patil, Pradip D, Mahajan, Umesh B, Patil, Kalpesh R, Chaudhari, Sandip, Patil, Chandragouda R, Agrawal, Yogeeta O, Ojha, Shreesh, Goyal, Sameer N
Médium: Artigo
Jazyk:Inglês
Vydáno: Dove Medical Press 2017
Témata:
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC5446975/
https://ncbi.nlm.nih.gov/pubmed/28579755
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/DDDT.S133453
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!